Invention Grant
![Pyrazolo[1,5-A]pyrimidines as antiviral agents](/docs/US/2016-03-08/US09278975B2/abs.jpg.600x600.jpg)
- Patent Title: Pyrazolo[1,5-A]pyrimidines as antiviral agents
-
Application No.: US14566340Application Date: 2014-12-10
-
Publication No.: US09278975B2Publication Date: 2016-03-08
- Inventor: Michael Sangi
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Agent Steven R. Eck
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/519 ; C07D487/08 ; A61K31/538 ; C07F9/6561 ; A61K31/675 ; A61K45/06
![Pyrazolo[1,5-A]pyrimidines as antiviral agents](/abs-image/US/2016/03/08/US09278975B2/abs.jpg.150x150.jpg)
Abstract:
The invention provides compounds and pharmaceutically acceptable salts and esters and compositions thereof, for treating viral infections. The compounds and compositions are useful for treating Pneumovirinae virus infection including Human respiratory syncytial virus infections.
Public/Granted literature
- US20150166546A1 PYRAZOLO[1,5-A]PYRIMIDINES AS ANTIVIRAL AGENTS Public/Granted day:2015-06-18
Information query
